Literature DB >> 12957837

Signaling the brain in systemic inflammation: the role of perivascular cells.

Jennifer C Schiltz1, Paul E Sawchenko.   

Abstract

Cytokines released from activated immune cells can act on the brain to elicit a range of centrally mediated acute phase responses. Several lines of evidence point to the barriers between the brain and its fluid environments, mainly cells associated with the cerebral vasculature, as critical sites for the transduction of circulating cytokine signals, and the initiation of brain responses to them by virtue of their capacity to produce local signaling molecules, notably prostaglandins. While it was initially assumed that such functions were the province of the vascular endothelium, recent work has identified a subset of marrow-derived brain macrophages, termed perivascular cells, as exhibiting the greater sensitivity to prostanoid synthesis induced by systemic cytokine or endotoxin challenges. Application of a novel liposome-based targeting method supports a critical involvement of brain macrophages, and their capacity to manifest induced prostanoid synthesis, in the interleukin-1-induced recruitment of control circuitry governing at least one acute phase response (hypothalamo-pituitary-adrenal axis activation), and suggests a two-way interaction between perivascular and endothelial cells in monitoring circulating cytokine signals. The ability to selectively manipulate perivascular cells holds promise for further informing mechanisms of immune-to-brain, and for intervening in pathologies that may result from dysfunction of such interactions.

Entities:  

Mesh:

Year:  2003        PMID: 12957837     DOI: 10.2741/1211

Source DB:  PubMed          Journal:  Front Biosci        ISSN: 1093-4715


  35 in total

Review 1.  Changing face of hepatic encephalopathy: role of inflammation and oxidative stress.

Authors:  Amit S Seyan; Robin D Hughes; Debbie L Shawcross
Journal:  World J Gastroenterol       Date:  2010-07-21       Impact factor: 5.742

Review 2.  Inflammation: A novel target of current therapies for hepatic encephalopathy in liver cirrhosis.

Authors:  Ming Luo; Jian-Yang Guo; Wu-Kui Cao
Journal:  World J Gastroenterol       Date:  2015-11-07       Impact factor: 5.742

3.  Role of ammonia and inflammation in minimal hepatic encephalopathy.

Authors:  D L Shawcross; G Wright; S W M Olde Damink; R Jalan
Journal:  Metab Brain Dis       Date:  2007-03       Impact factor: 3.584

Review 4.  Brain edema in acute liver failure: can it be prevented? Can it be treated?

Authors:  Andres T Blei
Journal:  J Hepatol       Date:  2007-02-05       Impact factor: 25.083

Review 5.  Integrating neuroimmune systems in the neurobiology of depression.

Authors:  Eric S Wohleb; Tina Franklin; Masaaki Iwata; Ronald S Duman
Journal:  Nat Rev Neurosci       Date:  2016-06-09       Impact factor: 34.870

Review 6.  Danger Signals and Inflammasomes: Stress-Evoked Sterile Inflammation in Mood Disorders.

Authors:  Monika Fleshner; Matthew Frank; Steven F Maier
Journal:  Neuropsychopharmacology       Date:  2016-07-14       Impact factor: 7.853

7.  Neural controls of prostaglandin 2 pyrogenic, tachycardic, and anorexic actions are anatomically distributed.

Authors:  Karolina P Skibicka; Amber L Alhadeff; Theresa M Leichner; Harvey J Grill
Journal:  Endocrinology       Date:  2011-03-29       Impact factor: 4.736

Review 8.  Stress-induced glucocorticoids as a neuroendocrine alarm signal of danger.

Authors:  Matthew G Frank; Linda R Watkins; Steven F Maier
Journal:  Brain Behav Immun       Date:  2013-03-01       Impact factor: 7.217

Review 9.  Rostral Ventrolateral Medulla and Hypertension.

Authors:  Patrice G Guyenet; Ruth L Stornetta; Benjamin B Holloway; George M P R Souza; Stephen B G Abbott
Journal:  Hypertension       Date:  2018-09       Impact factor: 10.190

10.  Thermoeffector neuronal pathways in fever: a study in rats showing a new role of the locus coeruleus.

Authors:  Maria C Almeida; Alexandre A Steiner; Norberto C Coimbra; Luiz G S Branco
Journal:  J Physiol       Date:  2004-05-14       Impact factor: 5.182

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.